Remote Monitored Systems PLC (LON:RMS) has reported that its subsidiaries, Geocurve and GyroMetric, saw increased sales and revenues across 2018. Big Pic in November. The chief financial officer of Silence Therapeutics PLC (LON:SLN), David Ellam, has left the gene editing specialist with immediate effect.
OptiBiotix Health plc (LON:OPTI) has inked a distribution agreement that will see its cholesterol and blood pressure product sold in Russia and Kazakhstan. In the latest of a series of similar commercial deals, the company is teaming up with SilvExpo, a local pharmaceutical and nutraceutical business.
Columbus Energy Resources PLC (LON:CERP) confirmed that it achieved the targeted end of year peak production rate of 1,000 barrels of oil per day, with the help of the asset acquisition. The Trinidad-focused company, in a statement, said that output hit 1,021 bopd in late December while the average rate for the fourth quarter amounted to 670 bopd.
The chief financial officer of Silence Therapeutics PLC (LON:SLN), David Ellam, has left the gene editing specialist with immediate effect. Silence’s group head of financial planning and analysis, Rob Quinn, will take on Ellam’s responsibilities for the time being whilst a permanent successor is found.
Anglo African Oil & Gas PLC (LON:AAOG) has raised gross proceeds of £6.0mln through a share placing to provide the funds required to complete the drilling of well TLP-103C at its Tilapia field in the Republic of the Congo. The independent oil and gas developer, which saw its shares rise on Monday after it confirmed multiple discoveries from the TLP-103 well, said it has placed 60mln new ordinary shares with investors at a price of 10p each.
ValiRx Plc (LON:VAL) has given its support to the UK government’s new long-term plan, which was unveiled on Monday. In the ten-year plan, NHS bosses said they wanted to find ways to detect cancers earlier. Currently, only half of people diagnosed with the disease are identified early on – at stage one or two.
Sunrise Resources Plc (LON:SRES) has raised £350,000 through a share placing to support activities at the CS pozzolan-perlite project in Nevada. It is selling some 291.6mln new shares priced at 0.12p each.
Salt Lake Potash Limited (LON:S04) (ASX:SO4) said it has now completed a placing of 31.0mln new ordinary shares to raise gross proceeds of A$13.0mln, first announced on 9 November 2018. The group said the second tranche comprising 1,702,381 ordinary shares were placed at a price of A$0.42 each, including 952,381 shares subscribed for by Salt Lake’s CEO, Tony Swiericzuk, and 750,000 shares by its chairman, Ian Middlemas. Proceeds will be used to fund the construction of the Williamson Ponds and dewatering of the Williamson Pit, as well as ongoing development of on-lake infrastructure, exploration and feasibility studies, and general working capital, the company said.